FDA.reportPublic FDA data

deflazacort 22.75 MG/ML Oral Suspension [Pyquvi]

RxCUI
2719198
RxNorm name
deflazacort 22.75 MG/ML Oral Suspension [Pyquvi]
Display name
deflazacort 22.75 MG/ML Oral Suspension [Pyquvi]
Full name
deflazacort 22.75 MG/ML Oral Suspension [Pyquvi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PYQUVIDEFLAZACORTAucta Pharmaceuticals, Inc.39854f19-d8be-6438-e063-6394a90a94222025-07-09Warnings, Adverse reactionsExact identifier
rxcui: 2719198

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39854f19-d8be-6438-e063-6394a90a9422Pyquvi 22.75 MG/mL Oral Suspension [PSN] · deflazacort 22.75 MG/ML Oral Suspension [Pyquvi] [SBD] · Pyquvi 22.75 MG/ML Oral Suspension [SY]31These highlights do not include all the information needed to use PYQUVI safely and effectively. See full prescribing information for PYQUVI. PYQUVI TM (deflazacort) oral suspension Initial U.S. Approval: 201720250709